Alimera Sciences Proposes Public Offering of Common Stock
10 août 2016 16h01 HE
|
Alimera Sciences, Inc.
ATLANTA, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a pharmaceutical company that specializes in research, development and commercialization of...
Alimera Sciences announces clinical presentations and sponsored Symposia at ASRS 2016 Annual meeting
09 août 2016 07h30 HE
|
Alimera Sciences, Inc.
ATLANTA, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...
Alimera Sciences to Report Fourth Quarter 2015 Financial Results on March 2, 2016
18 févr. 2016 07h30 HE
|
Alimera Sciences, Inc.
ALPHARETTA, Ga., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...